Croda strikes deal with Pfizer to supply COVID-19 vaccine additives

Nov 10 (Reuters) - Croda International Plc said on Tuesday it has entered into a deal with Pfizer Inc to supply additives for manufacturing its COVID-19 vaccine candidate, sending the shares of the UK-based specialty chemical company to a record high.

The contract with Pfizer runs for five years and awards Croda an initial supply contract for four component excipients used in the production of the vaccine candidate for the first three years of the contract, Croda said.


Reuters Breakingviews is the world's leading source of agenda-setting financial insight. As the Reuters brand for financial commentary, we dissect the big business and economic stories as they break around the world every day. A global team of about 30 correspondents in New York, London, Hong Kong and other major cities provides expert analysis in real time.

Sign up for a free trial of our full service at and follow us on Twitter @Breakingviews and at All opinions expressed are those of the authors.